Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

scientific article published on 14 January 2020

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2147/OPTH.S228838
P932PMC publication ID6969676
P698PubMed publication ID32021076

P50authorAlan G KabatQ64819592
Jodi LuchsQ89536538
P2093author name stringPaul Karpecki
Bridgitte Shen Lee
Jason Bacharach
P2860cites workOver the counter (OTC) artificial tear drops for dry eye syndromeQ24186110
Controlled ocular drug delivery with nanomicellesQ27012087
Autologous serum eye drops for dry eye.Q30235522
Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfactionQ35010238
Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular DeliveryQ35565484
Long-term Natural History of Dry Eye Disease from the Patient's PerspectiveQ36494967
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled StudyQ36877000
TFOS DEWS II Diagnostic Methodology reportQ38652978
TFOS DEWS II iatrogenic report.Q38652981
TFOS DEWS II pathophysiology reportQ38652987
TFOS DEWS II Epidemiology ReportQ38652994
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial effortsQ39185845
TFOS DEWS II Management and Therapy ReportQ39453364
Dietary Supplementation with a Combination of Lactoferrin, Fish Oil, and Enterococcus faecium WB2000 for Treating Dry Eye: A Rat Model and Human Clinical StudyQ40078017
Predictors of Discordance between Symptoms and Signs in Dry Eye DiseaseQ40407061
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study GroupQ41730611
Epidemiology of discordance between symptoms and signs of dry eye.Q47642988
The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.Q50480678
Migration of Cosmetic Products into the Tear Film.Q51048830
Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye.Q52608828
One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease.Q53836361
The Correlation between Daily Lens Wear Duration and Dry Eye Syndrome.Q55115758
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye diseaseQ57484944
Investigating the effect of eye cosmetics on the tear film: current insightsQ57593846
Oral Alcohol Administration Disturbs Tear Film and Ocular SurfaceQ58336800
Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveysQ79526746
n-3 Fatty Acid Supplementation for the Treatment of Dry Eye DiseaseQ88350776
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye DiseaseQ91291525
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 StudiesQ91885064
A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye DiseaseQ92970826
Effect of calorie restriction on change in lacrimal gland with ageQ95382642
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjecteye diseaseQ3041498
P304page(s)119-126
P577publication date2020-01-14
P1433published inClinical OphthalmologyQ5133782
P1476titleManaging Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies
P478volume14

Search more.